SOLIFENACIN APOTEX

5MG TBL FLM 100 II

SÚKL code 0192871
Name of the product SOLIFENACIN APOTEX 5 MG POTAHOVANÉ TABLETY
_MA_MEDICATION_DETAIL_INFO_MED_NAME i SOLIFENACIN APOTEX
Supplement 5MG TBL FLM 100 II
Strenght 5MG
Pharmaceutical form Film-coated tablet
Package 100 II
Route Oral use
Language of the pack Czech
Wrap type Blister
Legal status na lékařský předpis
Active substance SOLIFENACIN SUCCINATE (SOLIFENACINI SUCCINAS)
ATC group G04BD08
ATC group name SOLIFENACIN

Marketing authorisation information

Registration Number 73/ 236/12-C
Type of MA A mutual recognition procedure (MRP, DCP), where CZ is Reference member state
MA status B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till)
Placed on the market till 31. 01. 2018
MA Holder Apotex Europe B.V., Leiden
MA Holder country NIZOZEMSKO
Actual MA holder Apotex Europe B.V., Leiden
Actual MA holder country NIZOZEMSKO

Back to list